|
IFT81 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.62809999999714E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.609000E-04 |
| Normal-vs-Stage2 |
1.164450E-01 |
| Normal-vs-Stage3 |
1.061000E-01 |
| Normal-vs-Stage4 |
9.157300E-03 |
| Stage1-vs-Stage2 |
8.869800E-01 |
| Stage1-vs-Stage3 |
5.917800E-01 |
| Stage1-vs-Stage4 |
8.266600E-01 |
| Stage2-vs-Stage3 |
7.870600E-01 |
| Stage2-vs-Stage4 |
7.682800E-01 |
| Stage3-vs-Stage4 |
5.627200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.93180000000504E-05 |
| Normal-vs-AfricanAmerican |
1.260560E-03 |
| Normal-vs-Asian |
8.562600E-01 |
| Caucasian-vs-AfricanAmerican |
8.042600E-01 |
| Caucasian-vs-Asian |
3.188400E-01 |
| AfricanAmerican-vs-Asian |
2.661400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.049500E-04 |
| Normal-vs-Female |
1.422570E-04 |
| Male-vs-Female |
2.305800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.808300E-02 |
| Normal-vs-Extreme_Weight |
3.248500E-02 |
| Normal-vs-Obese |
4.756300E-04 |
| Normal-vs-Extreme_Obese |
3.479600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.562200E-01 |
| Normal_Weight-vs-Obese |
2.468800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.070400E-01 |
| Extreme_Weight-vs-Obese |
1.253160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.884200E-01 |
| Obese-vs-Extreme_Obese |
3.570200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.590200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.85139999997475E-06 |
| Normal-vs-Age(61-80Yrs) |
6.817000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.634600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.982800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.538100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.516010E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.550400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.895700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.826000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.77640000381874E-08 |
| Normal-VS-Type2 PRCC |
8.906800E-01 |
| Normal-VS-KIRP CIMP |
6.295700E-02 |
| Normal-VS-Unclassified PRCC |
6.138700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.13570000004337E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.374400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.870400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.415000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.518300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.926200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.310800E-01 |
| Normal-vs-N1 |
3.975700E-03 |
| Normal-vs-N2 |
3.716400E-01 |
| N0-vs-N1 |
1.725990E-02 |
| N0-vs-N2 |
8.039200E-01 |
| N1-vs-N2 |
3.585800E-01 |
|
|
